GlaxoSmithKline Plc has announced the start of a new academic collaboration to discover future drugs, this time with Yale University in New Haven, Connecticut, US. The project will focus on proteolysis targeting chimeric molecules. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
